BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29654218)

  • 1. p53: emerging roles in stem cells, development and beyond.
    Jain AK; Barton MC
    Development; 2018 Apr; 145(8):. PubMed ID: 29654218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56.
    Jain AK; Xi Y; McCarthy R; Allton K; Akdemir KC; Patel LR; Aronow B; Lin C; Li W; Yang L; Barton MC
    Mol Cell; 2016 Dec; 64(5):967-981. PubMed ID: 27912097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms underlying differentiation of primordial germ cells and their reprogramming to pluripotential stem cells].
    Matsui Y
    Seikagaku; 2014 Dec; 86(6):726-34. PubMed ID: 25675810
    [No Abstract]   [Full Text] [Related]  

  • 4. An Updated View of the Roles of p53 in Embryonic Stem Cells.
    Ayaz G; Yan H; Malik N; Huang J
    Stem Cells; 2022 Oct; 40(10):883-891. PubMed ID: 35904997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 switches off pluripotency on differentiation.
    Lin T; Lin Y
    Stem Cell Res Ther; 2017 Feb; 8(1):44. PubMed ID: 28241890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and stem cells: new developments and new concerns.
    Zhao T; Xu Y
    Trends Cell Biol; 2010 Mar; 20(3):170-5. PubMed ID: 20061153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin ligase LIN41/TRIM71 targets p53 to antagonize cell death and differentiation pathways during stem cell differentiation.
    Nguyen DTT; Richter D; Michel G; Mitschka S; Kolanus W; Cuevas E; Wulczyn FG
    Cell Death Differ; 2017 Jun; 24(6):1063-1078. PubMed ID: 28430184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Develop-WNTs in somatic cell reprogramming.
    Merrill BJ
    Cell Stem Cell; 2008 Nov; 3(5):465-6. PubMed ID: 18983957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling.
    Lee DF; Su J; Ang YS; Carvajal-Vergara X; Mulero-Navarro S; Pereira CF; Gingold J; Wang HL; Zhao R; Sevilla A; Darr H; Williamson AJ; Chang B; Niu X; Aguilo F; Flores ER; Sher YP; Hung MC; Whetton AD; Gelb BD; Moore KA; Snoeck HW; Ma'ayan A; Schaniel C; Lemischka IR
    Cell Stem Cell; 2012 Aug; 11(2):179-94. PubMed ID: 22862944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [P53, ARF and P16: the last defence against reprogrammation].
    Dijon-Grinand M; De Vos J
    Med Sci (Paris); 2009 Oct; 25(10):793-4. PubMed ID: 19849977
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of chromatin accessibility in p53 deficient spermatogonial stem cells for high frequency transformation into pluripotent state.
    Liu S; Wei R; Liu H; Liu R; Li P; Zhang X; Wei W; Zhao X; Li X; Yang Y; Fu X; Zou K
    Cell Prolif; 2022 Mar; 55(3):e13195. PubMed ID: 35119145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two supporting factors greatly improve the efficiency of human iPSC generation.
    Zhao Y; Yin X; Qin H; Zhu F; Liu H; Yang W; Zhang Q; Xiang C; Hou P; Song Z; Liu Y; Yong J; Zhang P; Cai J; Liu M; Li H; Li Y; Qu X; Cui K; Zhang W; Xiang T; Wu Y; Zhao Y; Liu C; Yu C; Yuan K; Lou J; Ding M; Deng H
    Cell Stem Cell; 2008 Nov; 3(5):475-9. PubMed ID: 18983962
    [No Abstract]   [Full Text] [Related]  

  • 14. Sirt1, p53, and p38(MAPK) are crucial regulators of detrimental phenotypes of embryonic stem cells with Max expression ablation.
    Hishida T; Nozaki Y; Nakachi Y; Mizuno Y; Iseki H; Katano M; Kamon M; Hirasaki M; Nishimoto M; Okazaki Y; Okuda A
    Stem Cells; 2012 Aug; 30(8):1634-44. PubMed ID: 22696478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation.
    Yi L; Lu C; Hu W; Sun Y; Levine AJ
    Cancer Res; 2012 Nov; 72(21):5635-45. PubMed ID: 22964580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell research. Recipe for induced pluripotent stem cells just got clearer.
    Normile D
    Science; 2009 Aug; 325(5942):803. PubMed ID: 19679782
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNA regulation of stem cell fate.
    Li Q; Gregory RI
    Cell Stem Cell; 2008 Mar; 2(3):195-6. PubMed ID: 18371442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 orchestrates between normal differentiation and cancer.
    Rivlin N; Koifman G; Rotter V
    Semin Cancer Biol; 2015 Jun; 32():10-7. PubMed ID: 24406212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new route to human embryonic stem cells.
    Trounson A; Daley GQ; Pasque V; Plath K
    Nat Med; 2013 Jul; 19(7):820-1. PubMed ID: 23836223
    [No Abstract]   [Full Text] [Related]  

  • 20. Pluripotent states of human embryonic stem cells.
    Chen Y; Lai D
    Cell Reprogram; 2015 Feb; 17(1):1-6. PubMed ID: 25393391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.